|
UHMK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.43279999999824E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.993900E-04 |
| Normal-vs-Stage2 |
8.408800E-04 |
| Normal-vs-Stage3 |
4.15569999999699E-05 |
| Normal-vs-Stage4 |
1.057720E-03 |
| Stage1-vs-Stage2 |
6.614600E-01 |
| Stage1-vs-Stage3 |
4.111600E-01 |
| Stage1-vs-Stage4 |
6.957800E-01 |
| Stage2-vs-Stage3 |
8.709200E-01 |
| Stage2-vs-Stage4 |
9.628600E-01 |
| Stage3-vs-Stage4 |
8.272600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.811800E-04 |
| Normal-vs-AfricanAmerican |
7.785500E-02 |
| Normal-vs-Asian |
8.12260000000453E-05 |
| Caucasian-vs-AfricanAmerican |
4.509200E-01 |
| Caucasian-vs-Asian |
2.185600E-01 |
| AfricanAmerican-vs-Asian |
1.160620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.40320000016925E-07 |
| Normal-vs-Female |
4.605800E-04 |
| Male-vs-Female |
3.419700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.536700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.62390000005386E-06 |
| Normal-vs-Age(61-80Yrs) |
2.197900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.157880E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.102300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.370000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.475000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.909200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.941000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.782000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.736190E-01 |
| Classical-VS-Follicular |
1.388470E-02 |
| Classical-VS-Other |
3.496700E-03 |
| Classical-VS-Normal |
2.100800E-03 |
| Tall-VS-Follicular |
8.289600E-01 |
| Tall-VS-Other |
1.176430E-01 |
| Tall-VS-Normal |
3.603300E-04 |
| Follicular-VS-Other |
1.764980E-01 |
| Follicular-VS-Normal |
1.08470000004246E-06 |
| Other-VS-Normal |
6.635000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.35839999995768E-06 |
| Normal-vs-N1 |
7.427600E-04 |
| N0-vs-N1 |
9.135400E-01 |
|
|
